Skip to content
Christopher T. Richardson, M.D., Ph.D.

Christopher T. Richardson, M.D., Ph.D.

Dermatology

4.8 out of 5 stars
UR Medicine Faculty The University of Rochester Medical Faculty Group (URMFG) consists of over 900 specialist and primary care providers spanning 19 departments. URMFG is certified by the National Committee for Quality Assurance.
Accountable Health Partner Accountable Health Partners (AHP) is a network of over 2,000 community and UR medical faculty and a dozen leading hospitals throughout the region. AHP offers a full range of care.
Accepting New Patients

Contact

Appointment (585) 275-7546

Locations

Dermatology - College Town - Rochester

College Town
40 Celebration Drive
Rochester, NY 14620

About Me

Dr. Christopher Richardson is an Associate Professor in the Department of Dermatology and Division of Allergy, Immunology and Rheumatology (AIR) in the Department of Medicine. He completed his medical school and dermatology training at the University of Rochester. He practices general dermatology w...
Dr. Christopher Richardson is an Associate Professor in the Department of Dermatology and Division of Allergy, Immunology and Rheumatology (AIR) in the Department of Medicine. He completed his medical school and dermatology training at the University of Rochester. He practices general dermatology with an emphasis on autoimmune and rheumatologic skin diseases, in particular lupus, dermatomyositis, and scleroderma.

Certified Specialties

Dermatology - American Board of Dermatology

Faculty Appointments

Associate Professor - Department of Dermatology (SMD)

Associate Professor - Department of Medicine, Allergy/Immunology and Rheumatology (SMD) - Joint

Credentials

Residency & Fellowship

Residency, Dermatology, University of Rochester Medical Center. 2014 - 2017

Internship, Internal Medicine, University of Rochester Medical Center. 2013 - 2014

Education

MD | University of Rochester School of Medicine/Dentistry (USA). 2013

Awards

Alpha Omega Alpha (AOA) Honor Medical Society, Alumnae Inductee. 2024

Medical Dermatology Society Mentorship Award. 2017

Victor Meyer Emmel Prize in Histology. 2004

Research

Dr. Richardson is an immunologist who studies autoimmune diseases of the skin. Much of his research experience has focused on the role of B cells and antibodies in cutaneous and systemic lupus erythematosus. He has ongoing research projects involving cutaneous lupus, dermatomyositis, and scleroderm...
Dr. Richardson is an immunologist who studies autoimmune diseases of the skin. Much of his research experience has focused on the role of B cells and antibodies in cutaneous and systemic lupus erythematosus. He has ongoing research projects involving cutaneous lupus, dermatomyositis, and scleroderma. He is also involved in clinical trials for these conditions.

Research Lab

Human Skin Immunology

Visit Research Lab Website

Publications

Journal Articles

Identifying care gaps and referral patterns in acute dermatology at urgent care centers.

Rahman SM, Orengo AR, Bowden A, Green CB, Pentland AP, Richardson CT, De Benedetto A, Plovanich M, Wolf JR

Archives of dermatological research.. 2025 January 28317 (1):315. Epub 01/28/2025.

Ruxolitinib cream for discoid lupus erythematosus: an open-label pilot study of ten subjects.

Bender AM, Laageide L, Kaur J, Babkowski N, Richardson CT

Journal of the American Academy of Dermatology.. 2024 November 26 Epub 11/26/2024.

Identifying Care Gaps and Referral Patterns in Acute Dermatology at Urgent Care Centers.

Rahman SM, Bowden A, Green CB, Pentland AP, Richardson CT, DeBenedetto A, Plovanich M, Wolf JR

Research square.. 2024 August 14 Epub 08/14/2024.

Lack of Cutaneous B Cells Differentiates Lupus-Like Skin Disease in MRL/lpr Mice from Human Discoid Lupus.

Yon J, Curran T, Richardson CT

The Journal of investigative dermatology.. 2024 June 144 (6):1392-1394.e1. Epub 12/13/2023.

Rapid response of omalizumab-resistant chronic urticaria to acalabrutinib.

Guy DR, Mizes A, Richardson CT

JAAD case reports.. 2024 May 47 :47-49. Epub 03/15/2024.

Wong-type dermatomyositis with interstitial lung disease and anti-SRP and -PM/Scl antibodies treated with intravenous immunoglobulin.

Kowalski EH, Kenney HM, Richardson CT

JAAD case reports.. 2023 November 41 :26-29. Epub 09/09/2023.

Successful treatment of severe chronic cutaneous lupus with anifrolumab: A series of 6 cases.

Kowalski EH, Stolarczyk A, Richardson CT

JAAD case reports.. 2023 July 37 :21-29. Epub 05/04/2023.

Differential effect of the 2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus on different cutaneous lupus subtypes.

Shah S, Esaa FS, Baughman L, Gadarowski MB, Richardson CT

Journal of the American Academy of Dermatology.. 2023 June 88 (6):1370-1372. Epub 02/04/2023.

Prominent B-Cell Signature Differentiates Discoid from Subacute Cutaneous Lupus Erythematosus.

Lerman I, Bawany F, Whitt W, Esaa F, Yon J, Babkowski N, Rapp MB, Scott GA, Anolik JH, Richardson CT

The Journal of investigative dermatology.. 2022 November 142 (11):2885-2895.e2. Epub 05/18/2022.

Multiple myositis-specific autoantibodies in dermatomyositis: 2 cases and review of the literature.

Narayan N, Richardson CT

JAAD case reports.. 2022 July 25 :72-74. Epub 06/03/2022.

Methotrexate injection site reactions: Case report and literature review.

Kaur J, Zambito J, Richardson CT

JAAD case reports.. 2022 May 23 :79-82. Epub 03/26/2022.

Locally recurrent primary cutaneous coccidioidomycosis.

Lee G, Scott GA, Munsiff SS, Richardson CT

JAAD case reports.. 2021 October 16 :161-163. Epub 09/08/2021.

Human cutaneous B cells: what do we really know?

Lerman I, Mitchell DC, Richardson CT

Annals of translational medicine.. 2021 March 9 (5):440. Epub 1900 01 01.

Degos Disease (Malignant Atrophic Papulosis) With Granular IgM on Direct Immunofluorescence.

Pukhalskaya T, Stiegler J, Scott G, Richardson CT, Smoller B

Cure?us.. 2021 January 1313 (1):e12677. Epub 01/13/2021.

Congenital absence of the skin secondary to the self-improving subtype of dystrophic epidermolysis bullosa with recurrent lesions throughout early childhood.

Dean O, Cusick EH, Grover R, Mercurio MG, Richardson CT

JAAD case reports.. 2021 January 7 :137-140. Epub 12/01/2020.

Remission of anti-TIF1? dermatomyositis after allogeneic hematopoietic stem cell transplant for myelodysplastic syndrome.

Bawany F, Tbakhi B, Mendler JH, Richardson CT, Bennett JM, Aljitawi OS

Blood advances.. 2020 November 244 (22):5698-5701. Epub 1900 01 01.

Autoimmune progesterone dermatitis mimicking facial erythromelalgia successfully treated with hysterectomy and bilateral salpingo-oophorectomy.

Whitt W, Stiegler JD, Richardson CT

JAAD case reports.. 2020 October 6 (10):1104-1106. Epub 08/28/2020.

A Spectrum of Skin Disease: How Staphylococcus aureus Colonization, Barrier Dysfunction, and Cytokines Shape the Skin.

Moran MC, Beck LA, Richardson CT

The Journal of investigative dermatology.. 2020 May 140 (5):941-944. Epub 1900 01 01.

A case of concurrent systemic sclerosis and scleredema.

Mitchell DC, Agnihothri R, Scott GA, Korman B, Richardson CT

JAAD case reports.. 2019 November 5 (11):940-942. Epub 10/24/2019.

An atypical clinical presentation of alopecia in 2 patients with systemic lupus erythematosus.

Lerman I, Agnihothri R, Scott GA, Richardson CT

JAAD case reports.. 2019 November 5 (11):953-956. Epub 10/24/2019.

Anti-TIF1gamma Antibody-Positive Dermatomyositis Associated with Myelodysplastic Syndrome: Response to Treatment.

Lerman I, Richardson CT

Cure?us.. 2019 September 2611 (9):e5775. Epub 09/26/2019.

A unique case of dermatomyositis associated with anti-TIF1? antibody and chondrosarcoma.

Dziwis J, Agnihothri R, Lieberman A, Richardson CT

JAAD case reports.. 2019 September 5 (9):828-830. Epub 09/03/2019.

Failure of B Cell Tolerance in CVID.

Richardson CT, Slack MA, Dhillon G, Marcus CZ, Barnard J, Palanichamy A, Sanz I, Looney RJ, Anolik JH

Frontiers in immunology.. 2019 10 :2881. Epub 12/10/2019.

Successful Treatment of Pemphigus Vulgaris With Ofatumumab.

Richardson C, Pentland A, Rapp M

Journal of drugs in dermatology : JDD.. 2018 December 117 (12):1338-1339. Epub 1900 01 01.

Evaluation of the Relationship between Alopecia Areata and Viral Antigen Exposure.

Richardson CT, Hayden MS, Gilmore ES, Poligone B

American journal of clinical dermatology.. 2018 February 19 (1):119-126. Epub 1900 01 01.

Doxycycline is an NF-?B inhibitor that induces apoptotic cell death in malignant T-cells.

Alexander-Savino CV, Hayden MS, Richardson C, Zhao J, Poligone B

Oncotarget.. 2016 November 157 (46):75954-75967. Epub 1900 01 01.

9G4+ autoantibodies are an important source of apoptotic cell reactivity associated with high levels of disease activity in systemic lupus erythematosus.

Jenks SA, Palmer E, Marin E, Hartson L, Chida AS, Richardson C, Sanz I

Arthritis and rheumatism.. 2013 December 65 (12):3165-75. Epub 1900 01 01.

Molecular basis of 9G4 B cell autoreactivity in human systemic lupus erythematosus.

Richardson C, Chida AS, Adlowitz D, Silver L, Fox E, Jenks SA, Palmer E, Wang Y, Heimburg-Molinaro J, Li QZ, Mohan C, Cummings R, Tipton C, Sanz I

The Journal of immunology : official journal of the American Association of Immunologists.. 2013 November 15191 (10):4926-39. Epub 10/09/2013.

Ratings & Comments

At URMC, we believe that patients should be empowered to make the right decisions regarding their personal healthcare. To do so, transparency is critical. URMC partners with Press Ganey, to survey our patients about all aspects of their care experience. We are now putting this pertinent information at your fingertips by displaying star ratings for our providers along with anonymous patient comments on our website. This will help you make better-informed choices about how and with whom you seek care. Click here to learn more about the surveys used to generate this vital information. Learn more about our survey process.

Ratings

Concern the care provider showed for your questions or worries

4.8 stars

Care provider's efforts to include you in decisions about your care

4.8 stars

Explanations the care provider gave you about your problem or condition

4.8 stars

Likelihood of recommending this care provider to others

4.8 stars

Care provider's discussion of any proposed treatment (options, risks, benefits, etc.)

4.7 stars

Patient Comments

5.0 stars

The very best Dr. I have In Rochester. He went far beyond what was expected as physician.

Oct 13, 2024

5.0 stars

Doctor Richardson and Doctor Deen were very thorough in their explanations on things and patient with listening to my issues.

Aug 17, 2024

5.0 stars

Dr. Richardson was kind, informative, conceded about my health..

Jul 21, 2024

5.0 stars

Good

Jul 12, 2024

5.0 stars

Dr Richardson and Stacey, his NP are a great example of professional team based patient-centered care!

May 23, 2024

5.0 stars

I felt very comfortable speaking with Dr. Richardson. He also was professional and friendly, and I felt that he really knew his "stuff." He calmed my concerns and encouraged me to reach out if I had concerns in the future.

Apr 24, 2024

5.0 stars

I consider Dr. C. Richardson to be one of the most intelligent doctors in the field of Dermatology.

Apr 21, 2024

5.0 stars

The provider showed excellent knowledge in what should be tried to help solve my issues.

Jan 11, 2024

5.0 stars

Dr Richardson and other staff have always been The Best of my care at SMH/UR

Nov 02, 2023

5.0 stars

I saw both a resident and Dr. Richardson. Both showed concern and clearly explained the lesion on my face, as well as explaining other ways these lesions might appear, their benign nature, and what to look for in suspicious growths on my skin. Use of sunscreen and a broad-brimmed hat were also recommended.

Jul 05, 2023